Influenza is one of the world’s most important diseases of humans and animals. Millions of people are affected by the disease each year, and its economic consequences are severe. In recent years, strains of avian influenza have emerged that scientists fear may soon become an important human pathogen. Research into this and other forms of influenza is essential if society is to prepare for flu strains that pose a serious risk to human health.
Scientists at the University of Wisconsin-Madison are among the world’s leaders in studies of influenza. UW-Madison research has already led to improved vaccine technology and has revealed important genetic targets for antiviral drugs that can be used to treat influenza and slow its spread. This research has been conducted safely on the UW-Madison campus for many years. The proposal to refurbish existing space at University Research Park to establish an Institute for Influenza Viral Research is an important new initiative that will enable UW-Madison to effectively contribute to improved vaccine technology and to public-health measures that will blunt future flu epidemics and pandemics.